Innospec Inc. (NASDAQ:IOSP – Free Report) – Investment analysts at Seaport Res Ptn dropped their Q4 2024 earnings per share estimates for shares of Innospec in a research report issued to clients and investors on Wednesday, January 22nd. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will post earnings per share of $1.36 for the quarter, down from their previous forecast of $1.38. The consensus estimate for Innospec’s current full-year earnings is $5.88 per share. Seaport Res Ptn also issued estimates for Innospec’s Q1 2025 earnings at $1.35 EPS, Q2 2025 earnings at $1.39 EPS, Q3 2025 earnings at $1.50 EPS, Q4 2025 earnings at $1.64 EPS, FY2025 earnings at $5.87 EPS and FY2026 earnings at $6.96 EPS.
Innospec (NASDAQ:IOSP – Get Free Report) last posted its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, hitting the consensus estimate of $1.35. The firm had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The company’s revenue for the quarter was down 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.59 earnings per share.
Read Our Latest Stock Report on IOSP
Innospec Trading Down 1.2 %
IOSP stock opened at $115.25 on Thursday. The business’s 50-day moving average price is $113.86 and its two-hundred day moving average price is $114.67. The firm has a market cap of $2.87 billion, a PE ratio of 20.11 and a beta of 1.09. Innospec has a 1-year low of $103.65 and a 1-year high of $133.71.
Institutional Trading of Innospec
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Pacer Advisors Inc. acquired a new stake in shares of Innospec in the fourth quarter valued at about $53,457,000. KBC Group NV grew its position in shares of Innospec by 82.3% in the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock valued at $136,000 after purchasing an additional 558 shares during the last quarter. Blue Trust Inc. grew its position in shares of Innospec by 54.2% in the fourth quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company’s stock valued at $136,000 after purchasing an additional 422 shares during the last quarter. Ballentine Partners LLC grew its position in shares of Innospec by 11.0% in the fourth quarter. Ballentine Partners LLC now owns 2,968 shares of the specialty chemicals company’s stock valued at $327,000 after purchasing an additional 295 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. grew its position in shares of Innospec by 0.6% in the fourth quarter. ZWJ Investment Counsel Inc. now owns 43,426 shares of the specialty chemicals company’s stock valued at $4,779,000 after purchasing an additional 279 shares during the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.
Insider Activity
In related news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the sale, the director now owns 9,028 shares of the company’s stock, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.52% of the company’s stock.
Innospec Increases Dividend
The company also recently declared a Semi-Annual dividend, which was paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th were issued a $0.79 dividend. This represents a dividend yield of 1.3%. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend was Monday, November 18th. Innospec’s payout ratio is 27.57%.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
- Five stocks we like better than Innospec
- Compound Interest and Why It Matters When Investing
- DigitalOcean’s AI Potential: A Game-Changer for Growth
- What is the FTSE 100 index?
- Supercharge Your Portfolio With These 3 Key Stocks
- What Are Some of the Best Large-Cap Stocks to Buy?
- Tide Shifts for 3M: How to Profit from the Rally
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.